On Friday, October 31st, we will be holding the "NQ Global Startup Gateway (Nakanoshima Cross Global Startup Creation and Hub Promotion Project) Kick-off Event (Information Session and Project Call)".

On Friday, October 31st, the "NQ Global Startup Gateway (Nakanoshima Cross Global Startup Creation and Hub Promotion Project) Kick-off Event (Information Session and Project Call)" will be held at the Qrossover Lounge Yume on the second floor of Nakanoshima Qross. At this event, in addition to introducing each project by the NQ Global Startup Gateway Joint Venture*10, which has been commissioned to carry out this project, Yoshiki Sawa, Chairman of the Future Medicine Promotion Organization, will be invited to speak about the outlook for the "Future Medicine Startup Ecosystem," which is being tackled through industry-government-academia collaboration.

This is your chance to be among the first to learn about new support programs in the life sciences field, including Global Acceleration (■1), COO Talent Development (■2), and AI x Drug Discovery Support (■3). (Project applications will also begin on the same day.)

Researchers, startups, business people, support organizations, and investors are all invited to join the new wave of innovation starting from Nakanoshima.

■1: Global Acceleration Program "Qross Health Accelerator"

In collaboration with Nakanoshima Qross, we are gathering promising startups in the life sciences field and promoting efforts to create startups that can be active globally by providing tailored SU support programs and overseas travel support programs.

AstraZeneca, Cambridge Consultants, MedTech ActuatorThe three companies will work together to plan and implement a tailored global acceleration program called "Qross Health Accelerator," leveraging each other's strengths and focusing on expansion into overseas markets.

■2: Nakanoshima Qross COO Human Resources Development Program

 Alloy Therapeutics' 82VS Venture Studios Based on the "COO (Chief Operating Officer) Human Resources Development Program" implemented by Nakanoshima Qross for US SUs, the program has been improved as a human resources development program for domestic SUs and is being offered to domestic SUs as the "Nakanoshima Qross COO Human Resources Development Program."

■3: NQ Bio-Catalyst AI Accelerator Program

Deep Intelligent PharmaThe program aims to transform promising startups into investable companies by leveraging cutting-edge AI technology and global industry expertise.

=====================
◆Date and time: Friday, October 31, 2025 15:00-18:30
Location: Nakanoshima Qross 2F Qrossover Lounge Yume
Capacity: 60 people on-site / 200 people online
◆Participation fee: Free
◆Organizer: Osaka Prefecture
◆ Co-organized by: Future Medicine Promotion Organization (Nakanoshima Qross)
◆Operator: NQ Global Startup Gateway
・MIRACLE SCIENCE INNOVATION Co., Ltd. (Representative organization) (Kita-ku, Osaka City, Representative Director and CEO Jun Miyagawa)
AstraZeneca K.K. (Kita-ku, Osaka City, Insights & Business Excellence Division, Innovation Partnership & i2.JP Director Liu Lei)
Cambridge Consultants Co., Ltd. (Minato-ku, Tokyo, CEO: Yoichi Ishige)
MedTech Actuator LLC (Kita-ku, Osaka, Japan General Manager: Junichi Azuma)
ALLOY THERAPEUTICS Co., Ltd. (Fujisawa City, Kanagawa Prefecture, Representative Director: Yoshihide Ishii)
・Deep Intelligent Pharma Co., Ltd. (Chuo-ku, Tokyo, CEO Lee Hsing)
ALLOY THERAPEUTICS Co., Ltd. (Fujisawa City, Kanagawa Prefecture, Representative Director: Yoshihide Ishii)
◆Details and application:https://20251031gateway.peatix.com/view
 =====================

■ Program

15:00- Opening remarks
Yoshiki Sawa (Chairman of the Board, Future Medicine Promotion Organization)

15:15-16:00 Panel discussion
Discussing the outlook for the "future medical startup ecosystem" undertaken through industry-government-academia collaboration

<Panelist>
Osaka Prefecture (speakers being coordinated)
Yu Moriguchi (Assistant to the President, Future Medicine Promotion Foundation / Specially Appointed Lecturer, International Medical Center, Osaka University)
Liu Lei (Director of Innovation Partnerships & i2.JP, Insights & Business Excellence Division, AstraZeneca K.K.)
Junichi Azuma (Japan General Manager, MedTech Actuator LLC)
Yoshihide Ishii (President and CEO, ALLOY THERAPEUTICS Co., Ltd.)

<Facilitator>
Yoshiki Sawa (Chairman of the Board, Future Medicine Promotion Organization)
Jun Miyagawa (Assistant President of the Future Medicine Promotion Foundation / CEO of MIRACLE SCINECE INNOVATION Inc.)

16:10-16:55 Explanation of each project and recruitment
①Global Startup Creation Support Project Global Acceleration Program
Liu Lei (Director of Innovation Partnerships & i2.JP, Insights & Business Excellence Division, AstraZeneca K.K.)
Junichi Azuma (Japan General Manager, MedTech Actuator LLC)
*Takuya Matsui (Head of Business Development, Medical Technology Division, Cambridge Consultants Co., Ltd.) will be unable to attend due to scheduling conflicts.

② Nakanoshima Qross COO Human Resources Development Program
Yoshihide Ishii (President and CEO, ALLOY THERAPEUTICS Co., Ltd.)

③NQ Bio-Catalyst AI Accelerator Program
Shinya Yamamoto (General Manager, Deep Intelligent Pharma Inc.)
*Online presentation

17:00-18:00 Networking & Q&A
=====================

■ Contact:
MIRACLE SCIENCE INNOVATION Co., Ltd., representative organization of the NQ Global Startup Gateway Joint Venture
Email Address:info@miracle-science-innovation.jp
Person in charge: Misato Yoshida